Skip to content

Evaluation of Motivationslyftet – a school-based intervention to improve self-efficacy, mental health and academic achievement among adolescents

A cluster-controlled trial evaluating the effects of Motivationslyftet, a universal school-based intervention, on self-efficacy, mental health, and academic achievement in Swedish adolescents aged 13–16 years

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14131022
Enrollment
500
Registered
2025-08-04
Start date
2025-08-25
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Promotion of self-efficacy, mental health and academic achievement in adolescents through a school-based programme Other

Interventions

Intervention schools (n = 3- 8) with adolescents (n = 150 -250) in grade 7 (aged 13-14) will be recruited in Sweden during spring/summer 2025 to implement the programme Motivationslyftet throughout th

Sponsors

Karolinska Institutet
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Schools in Sweden that already use the programme Motivationslyftet will be offered to participate in the study as intervention groups. Control schools will be matched based on the school's socioeconomic index. 2. All students in grade 7 (aged 13-14 years) from participating schools 3. Teachers from the included schools

Exclusion criteria

Exclusion criteria: 1. Schools that have used the programme Motivationslyftet or similar will not be invited to be control schools in the project. 2. Students who do not understand written Swedish, or who have conditions that prevent them from completing questionnaires independently, may be excluded from specific analyses. 3. Students in intervention schools who participated in the programme Motivationslyftet during middle school may be excluded from specific analyses.

Design outcomes

Primary

MeasureTime frame
Adolescents’ self-reported self-efficacy, assessed with the Swedish version (Löve et al., 2012) of the general self-efficacy scale (Schwarzer & Jerusalem, 2010) that has been validated in adolescents (Lönnfjord & Hagquist, 2018) at baseline (September- October 2025),post-intervention (April - June 2026) and follow-up (April- June 2028).

Secondary

MeasureTime frame
1. Academic achievement, school climate, and psychosomatic health measured by the Swedish items from the Health Behaviour in School-aged Children study (Folkhälsomyndigheten, 2023; World Health Organization, 2020) at baseline (September- October 2025), post-intervention (April - June 2026) and follow-up (April- June 2028). 2. Anxiety will be assessed using the short version of the Spence Children’s Anxiety Scale (Ahlen et al., 2018; Spence et al., 2003) at baseline (September- October 2025), post-intervention (April—June 2026), and follow-up (April—June 2028). 3. Self-esteem will be evaluated with the Rosenberg scale (Rosenberg, 1965) at baseline (September- October 2025), post-intervention (April - June 2026) and follow-up (April- June 2028). 4. Symptoms of stress will be measured with a Scandinavian scale (Elo et al., 2003) at baseline (September- October 2025), post-intervention (April - June 2026) and follow-up (April- June 2028). 5. Teachers’ perceptions of school climate and relations will be assessed in both intervention and control schools with the Pedagogical School Climate [PESOC] instrument, adapted and validated for teachers (Hultin et al., 2018) at baseline (September- October 2025), post-intervention (April - June 2026) and follow-up (April- June 2028). 6. Teachers in intervention schools will also answer questions regarding the perceived acceptability, appropriateness, and feasibility of implementing the Motivationslyftet programme in their schools (Weiner et al., 2017) at baseline (September- October 2025), post-intervention (April - June 2026) and follow-up (April- June 2028).

Countries

Sweden

Contacts

Public ContactSusanne Andermo
susanne.andermo@ki.se+46 8 52483902

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026